applying an in situ cytotoxic approach for ablating nk 1.1 cells , we have demonstrated that nk 1.1 cells differentially inhibit the recovery of hematopoietic stem cells ( cfu-s ) and their progenitor cells committed to granulocyte-macrophage differentiation from a sublethal dose of tbi ( 9 gy ) while not affecting the recovery of progenitor cells committed to either erythroid or megakaryocyte differentiation from tbi .
C0007634
cells
C0018956
hematopoietic stem cells